1154 related articles for article (PubMed ID: 17537387)
1. Ocular manifestations in antiphospholipid syndrome.
Suvajac G; Stojanovich L; Milenkovich S
Autoimmun Rev; 2007 Jun; 6(6):409-14. PubMed ID: 17537387
[TBL] [Abstract][Full Text] [Related]
2. Ocular manifestations of antiphospholipid (Hughes)' syndrome--minor features?
Coroi M; Bontas E; Defranceschi M; Bartos D; Dorobantu M
Oftalmologia; 2007; 51(3):16-22. PubMed ID: 18064949
[TBL] [Abstract][Full Text] [Related]
3. Ophthalmologic manifestations in primary antiphospholipid syndrome patients: A cross-sectional analysis of a primary antiphospholipid syndrome cohort (APS-Rio) and systematic review of the literature.
Franco AMM; Medina FMC; Balbi GGM; Levy RA; Signorelli F
Lupus; 2020 Oct; 29(12):1528-1543. PubMed ID: 32814509
[TBL] [Abstract][Full Text] [Related]
4. [Retinal vascular lesions in systemic lupus erythematosus and secondary antiphospholipid syndrome].
Ermakova NA; Alekberova ZS; Reshetniak TM; Kalashnikova LA; Kosheleva NM
Vestn Oftalmol; 2005; 121(5):31-6. PubMed ID: 16274063
[TBL] [Abstract][Full Text] [Related]
5. Ocular manifestations of the antiphospholipid syndrome.
Utz VM; Tang J
Br J Ophthalmol; 2011 Apr; 95(4):454-9. PubMed ID: 20693557
[TBL] [Abstract][Full Text] [Related]
6. [Antiphospholipid syndrome--the description of two cases].
Podrazilová L; Peterová V; Olejárová M; Seidl Z; Dostál C
Vnitr Lek; 2006 Jan; 52(1):89-94. PubMed ID: 16526206
[TBL] [Abstract][Full Text] [Related]
7. Antiphospholipid antibodies in pediatric systemic lupus erythematosus and the antiphospholipid syndrome.
Avcin T; Silverman ED
Lupus; 2007; 16(8):627-33. PubMed ID: 17711899
[TBL] [Abstract][Full Text] [Related]
8. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
[TBL] [Abstract][Full Text] [Related]
9. Isolated ocular cutaneous involvement in antiphospholipid syndrome.
Rahim A; Kumar P; Burns J; Sampath R
Orbit; 2012 Oct; 31(5):367-9. PubMed ID: 22758382
[TBL] [Abstract][Full Text] [Related]
10. [Antiphospholipid syndrome and changes in the eye].
Gerkowicz M; Latalska M; Kosior-Jarecka E; Kozioł-Montewka M; Pietraś-Trzpiel M
Klin Oczna; 2005; 107(1-3):143-6. PubMed ID: 16052828
[TBL] [Abstract][Full Text] [Related]
11. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
[TBL] [Abstract][Full Text] [Related]
12. Influence of antiphospholipid antibody levels and type on thrombotic manifestations: results from the Serbian National Cohort Study.
Stojanovich L; Markovic O; Marisavljevic D; Elezovic I; Ilijevski N; Stanisavljevic N
Lupus; 2012 Mar; 21(3):338-45. PubMed ID: 21993381
[TBL] [Abstract][Full Text] [Related]
13. Cardiac manifestations in antiphospholipid syndrome.
Soltész P; Szekanecz Z; Kiss E; Shoenfeld Y
Autoimmun Rev; 2007 Jun; 6(6):379-86. PubMed ID: 17537384
[TBL] [Abstract][Full Text] [Related]
14. [Primary antiphospholipid syndrome].
Popa A; Voinea L; Pop M; Stana D; Dascalu AM; Alexandrescu C; Ciuluvica R
Oftalmologia; 2008; 52(1):13-7. PubMed ID: 18714484
[TBL] [Abstract][Full Text] [Related]
15. Looking into the eyes of patients with antiphospholipid syndrome.
Yehudai D; Shoenfeld Y; Toubi E
Clin Rev Allergy Immunol; 2007 Apr; 32(2):192-7. PubMed ID: 17916993
[TBL] [Abstract][Full Text] [Related]
16. Antiphospholipid antibodies and migraine: a retrospective study of 428 patients with inflammatory connective tissue diseases.
Tănăsescu R; Nicolau A; Caraiola S; Ticmeanu M; Cojocaru IM; Frăsineanu A; Ionescu R; Hristea A; Ene A; Anghel D; Tănăsescu R; Băicuş C
Rom J Intern Med; 2007; 45(4):355-63. PubMed ID: 18767411
[TBL] [Abstract][Full Text] [Related]
17. Ophthalmologic manifestations in patients with antiphospholipid antibodies: Beware of iatrogenic complications.
Menet J; Agrinier N; Dufrost V; Conart JB; Wahl D; Duprez KA; Zuily S
Lupus; 2021 Oct; 30(11):1799-1807. PubMed ID: 34284674
[TBL] [Abstract][Full Text] [Related]
18. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
[TBL] [Abstract][Full Text] [Related]
19. Risk of thrombosis in patients with antiphospholipid antibodies and factor V Leiden mutation.
Pablos JL; Caliz RA; Carreira PE; Atsumi T; Serrano L; Amengual O; Santiago B; Khamashta MA; Hughes GR; Gomez-Reino JJ
J Rheumatol; 1999 Mar; 26(3):588-90. PubMed ID: 10090167
[TBL] [Abstract][Full Text] [Related]
20. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
Alpert D; Mandl LA; Erkan D; Yin W; Peerschke EI; Salmon JE
Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
